CellaVision reinforces management team with a Chief Operating Officer
CellaVision, which develops and sells products for routine analysis of blood and
other body fluids in health care services, has employed Stefan Bengtsson as
Chief Operating Officer (COO). Mr Bengtsson will take up the position
successively, starting on February 1, 2011.
As COO Mr Bengtsson will have the overall responsibility for CellaVision's
product supply, from development to delivery, and will be part of the management
team reporting to CEO Yvonne MÃ¥rtensson. Mr Bengtsson has more than 20 years
experience of medical device companies and has successfully led high-performing
teams in both business and elite-level sport.
"I'm very pleased that Stefan Bengtsson has decided to work with us. Stefan has
strong leadership qualities and great knowledge of how to run product
development and adapt production and organization in a vigorously growing
company. Demand for our products is greater than ever and our challenge is to
adapt our organization and processes to this strong growth in demand. The
recruitment is part of our growth strategy," says Yvonne MÃ¥rtensson,
CellaVision's CEO.
Stefan Bengtsson holds a Masters degree in engineering and his most recent
position was CEO of Presona AB, a leading supplier of compacting equipment in
the recycling industry. He has held leading positions in Gambro, Getinge and
Pharmacia and is a former player and trainer in the Swedish national league in
bandy.
For further information, please contact:
Yvonne MÃ¥rtensson, CEO, CellaVision AB
Telephone: 0708 33 77 82. Email:yvonne.martensson@cellavision.com
About CellaVision
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The analyses often constitute important
reference data for fast and correct diagnosis of illnesses, for example of
infections and serious cancers. CellaVision's products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge expertise
in image analysis, artificial intelligence and automated microscopy. In 2009
sales were SEK 109 million and sales continue to increase, with a growth target
of at least 15 % per year over an economic cycle. CellaVision's registered
office is in Lund and the company has subsidiaries in the USA, Canada and Japan.
The share is listed on the Nasdaq, OMX Stockholm, Small Cap list. Read more
atwww.cellavision.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
[HUG#1478921]
